PeptideStack
5.2kquestions
20kanswers
220users

What is the 0.9 % benzyl alcohol in bacteriostatic water actually doing in a multi-use vial?

Asked 12 Sept 2024Modified 21 months agoViewed 18k times
22

I have been reconstituting research-use lyophilised GLP-1 analogues with Bacteriostatic Water for Injection because that is what every protocol sheet says to use, and I have never questioned why. Now I would like to actually understand it.

What I think I know: bacteriostatic water is water for injection plus 0.9 % benzyl alcohol. What I do not know is what that 0.9 % is buying me in practice. Specifically:

  • Is benzyl alcohol killing organisms, or only stopping them multiplying? Those are very different things for a vial I re-enter eight or ten times.
  • Where does the "use within 28 days" number that gets repeated everywhere come from? Is it a peptide-degradation number or a preservative number?
  • How much benzyl alcohol is actually present in a reconstituted vial in absolute terms? Everyone quotes a percentage and nobody quotes milligrams, which makes it impossible to reason about.
  • Does the preservative do anything at all if the vial was already contaminated before I touched it?

I am not asking whether to use it — I am asking what mechanism I am relying on, so that I know which failure modes it does not cover. Research-use material, not for human use, and I am aware none of this is medical advice.

bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

112 questions
sterile-water
sterile-water

Preservative-free sterile water for injection: appropriate for a single-withdrawal presentation, a poor choice for anything you intend to open…

14 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
shareeditfollowflag
OK
askedoona_kekkonen16k1812 Sept 2024
2Worth separating two questions: what preserves the diluent bottle, and what preserves the reconstituted vial. They are not the same problem. – plate_count_9k 43 days ago
The 28-day figure has a specific compendial origin and it is not about the peptide at all. – Dr_Otto_Lindqvist 10 months ago
add a comment

4 Answers

Accepted answer first, then by votes
71

Accepted answer

Benzyl alcohol is bacteriostatic, not bactericidal, and not sporicidal at all. It suppresses replication of vegetative organisms introduced in small numbers during stopper entry. It will not sterilise a vial, it will not rescue a vial that already has a meaningful bioburden, and it does nothing whatsoever to endotoxin that is already present. Everything else follows from that one sentence.

What it is, in milligrams

Bacteriostatic Water for Injection USP is Water for Injection with 0.9 % w/v benzyl alcohol, which is 9 mg/mL. Work the actual numbers for a typical vial:

  • 2.00 mL diluent x 9 mg/mL = 18 mg benzyl alcohol in the reconstituted vial.
  • If a nominal 10 mg vial in 2.00 mL is drawn in 50 µL aliquots, each aliquot carries 50/1000 x 9 = 0.45 mg.
  • For scale, the EMA excipient guidance tolerance figure for benzyl alcohol in adults is 90 mg/kg/day; a 70 kg reference adult is therefore 6,300 mg/day. A 0.45 mg aliquot is roughly four orders of magnitude below that.

So in a research context the preservative load is chemically trivial in quantity. The interesting question was never toxicity — it is efficacy.

Where the 28 days comes from

USP <51> Antimicrobial Effectiveness Testing sets acceptance criteria for preserved injectable products: for bacteria, not less than a 1.0 log reduction from the initial count at day 7, not less than 3.0 log at day 14, and no increase from the day-14 count through day 28. Notice what that last clause actually promises — that the challenge organisms will not regrow for 28 days. That is the origin of the 28-day in-use convention. It is a preservative-performance endpoint, not a statement about peptide chemistry. A peptide can be perfectly intact at day 40 and the preservative claim still expired at day 28; equally a peptide can be badly degraded at day 10 while the preservative is still working fine.

Why multi-use vials need it at all

Any multiple-dose parenteral container is expected to contain an antimicrobial preservative precisely because it will be entered repeatedly, and each entry is an opportunity to drag skin flora or airborne organisms past the stopper. The preservative converts "one organism gets in on day 3" from an exponential growth curve into a flat line. Without it, a single Staphylococcus cell in a nutrient-poor but not nutrient-free solution at 4 °C has 25 days to do something with itself.

Preservative options, compared

DiluentPreservativeConcentrationTonicityTypical container
Sterile Water for Injection USPnonehypotonicsingle-dose
Bacteriostatic Water for Injection USPbenzyl alcohol0.9 % w/v (9 mg/mL)hypotonicmultiple-dose, commonly 30 mL
0.9 % Sodium Chloride Injection USPnoneisotonicsingle-dose
Bacteriostatic 0.9 % Sodium Chloride Injection USPbenzyl alcohol0.9 % w/visotonicmultiple-dose

Note the row that surprises people: bacteriostatic water is still hypotonic. Adding 9 mg/mL of benzyl alcohol does not make it isotonic. If tonicity matters for your application, bacteriostatic saline is the relevant product, not bacteriostatic water.

The failure modes it does not cover

Fungi and moulds are handled far more weakly than bacteria by the <51> criteria (no increase from initial count is the yeast/mould requirement, which is a much lower bar). Bacterial spores are not covered. Endotoxin is a heat-stable lipopolysaccharide fragment and is completely unaffected — a vial can be rendered organism-free and still be pyrogenic. And a vial that arrived non-sterile is not fixed by anything you add to it afterwards.

One last practical point: benzyl alcohol has genuine weak local anaesthetic activity, which is a large part of why preserved diluents are reported as more comfortable than plain water. That is a side effect of the preservative, not its purpose.

edited 29 Oct 2024 by aine_mulcahy — tightened the wording; no substantive change

shareimprove this answerflag
AM
answered · acceptedaine_mulcahy35k3816 Oct 2024
4The 9 mg/mL to 18 mg per vial conversion is the bit nobody ever writes down. Thank you. – Dr_Idris_Coulibaly 9 months ago
3Also worth saying: "no increase from the day 14 count" is a much weaker promise than most people hear when they read "preserved for 28 days". – Dr_Ilse_Vandenberg 8 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
34

Adding the diluent-side half of the problem, because the accepted answer covers the reconstituted vial well but the bottle on your bench matters too.

Bacteriostatic water is usually sold in a 30 mL multiple-dose vial, and that container is the thing the preservative was originally designed for. You will enter it once per reconstitution, so a bottle used across ten vials gets pierced ten times over several months. Without a preservative that bottle would be the single dirtiest object in the workflow, because it is the one item that is both repeatedly entered and stored for a long time.

Two consequences that follow:

  • Date the bottle at first entry, not at purchase. The unopened expiry on the label assumes an intact container closure. Once pierced, the 28-day in-use logic applies to the diluent as much as to anything you make with it. In practice a lot of people run a bottle for far longer than that; understand that you are then relying on the preservative outside its demonstrated window.
  • A 30 mL bottle is usually the wrong size. If you reconstitute 2 mL at a time, 30 mL is fifteen reconstitutions. Unless you are getting through that in a month, smaller containers waste less and spend less time open. This is one of the very few places where buying the small unit is the technically better choice rather than the more expensive one.

Sourcing: Bacteriostatic Water for Injection USP is a compendial article, so what you want is a product that names the compendial monograph on the label, states 0.9 % benzyl alcohol, and carries a lot number and expiry. Anything sold as "bacteriostatic solution" without a monograph reference, without a stated preservative concentration, or without a lot number is an unknown liquid. That is a much bigger risk to a peptide than any of the stability questions people worry about, because you have no idea of its pH, its conductivity, or what else is in it.

pH is the underappreciated variable here. Sterile and bacteriostatic water are unbuffered and their measured pH drifts with dissolved carbon dioxide, so the pH you actually reconstitute into is not a controlled quantity. For most GLP-1 analogues that is tolerable because the peptide plus residual buffer salts in the cake dominate the final pH — but it is one more reason to prefer a diluent whose identity you can verify.

shareimprove this answerflag
SB
answereds_bhattacharya42k385 Oct 2024
19

A counterweight, because there is a tendency to treat the preservative as a technique substitute.

The published clinical literature on multiple-dose vials in real use is not reassuring. Surveys of in-use vials in hospital and clinic settings have found contamination prevalence ranging from essentially zero in well-run units to double-digit percentages in poorly-run ones, and the discriminating variable is almost never the preservative — it is whether the stopper was swabbed and allowed to dry, whether a fresh needle was used per entry, and how long the vial sat out at room temperature. The preservative is a margin, not a mechanism.

Concretely, the things that actually change your outcome, ranked by effect size as best I can judge from the way vials go wrong:

  1. A fresh sterile needle for every single stopper entry. Re-entering with a used needle defeats everything else.
  2. Swab with 70 % isopropanol and let it dry. Wet alcohol carries organisms into the puncture; dry alcohol has already done its work.
  3. Keep the vial cold and keep it in the dark between entries. Time-at-room-temperature is the variable that converts a small bioburden into a visible one.
  4. Reconstitute the volume you will actually use in the window you will actually use it. A 5 mL reconstitution you will finish in nine weeks is a worse idea than two 2.5 mL reconstitutions.

Benzyl alcohol sits somewhere below all four of those. Use it, but do not let it make you casual.

shareimprove this answerflag
KA
answeredkwn_analytical89k2488 Nov 2024
8

One mechanistic footnote that the other answers gesture at without stating. Benzyl alcohol works by partitioning into the lipid bilayer and increasing membrane fluidity to the point where the membrane can no longer maintain gradients. It is the same broad mechanism as most short-chain alcohol antimicrobials, and it explains two things:

  • Why it is bacteriostatic rather than bactericidal at 0.9 %. Membrane perturbation is concentration-dependent and reversible. At 0.9 % it is enough to stall a cell; ethanol at 70 % is enough to lyse one. The effect is graded, not binary, and diluting the preservative — for example by using a 1:1 mix of bacteriostatic and plain sterile water to make up a larger volume — genuinely reduces its efficacy proportionally. If you do that, you no longer have a USP-preserved solution.
  • Why it is contraindicated in neonates. Benzyl alcohol clearance depends on oxidation to benzoic acid and conjugation to hippuric acid, and neonates conjugate poorly, which is the basis of the historical gasping syndrome reports from benzyl-alcohol-containing flush solutions. This is not a research-vial concern in any normal sense, but it is why "benzyl alcohol free" exists as a product category and why you should not assume the preservative is universally innocuous.

The practical takeaway is only that the 0.9 % figure is not arbitrary and is not a "more is better" dial. It is the concentration at which the compendial preservative-effectiveness criteria are met with a workable margin, and both halving it and doubling it are worse choices.

shareimprove this answerflag
DO
answeredDr_Lena_Ostrowska42k3827 Oct 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.